Chicago Partners Investment Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Chicago Partners Investment Group’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.44M	Buy	2,209 +208	+10%	+$142K	0.03%	495
2026 Q1	$1.49M	Buy	2,001 +656	+49%	+$502K	0.03%	408
2025 Q4	$1.01M	Buy	1,345 +400	+42%	+$272K	0.03%	469
2025 Q3	$618K	Buy	+945	New	+$534K	0.02%	585
2021 Q4	–	Sell	-362	Closed	-$227K	–	600
2021 Q3	$227K	Buy	+362	New	+$225K	0.02%	513
2020 Q3	–	Sell	-433	Closed	-$276K	–	421
2020 Q2	$276K	Buy	+433	New	+$246K	0.03%	306
2015 Q2	–	Sell	-18	Closed	-$7K	–	483
2015 Q1	$7K	Buy	18 +2	+13%	+$848	﹤0.01%	395
2014 Q4	$7K	Buy	+16	New	+$6.29K	﹤0.01%	411

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Chicago Partners Investment Group's REGN Position: Q2 2026 in Review

Chicago Partners Investment Group increased its Regeneron Pharmaceuticals (REGN) stake by 10% in Q2 2026, buying an estimated $142K and bringing the position to 2,209 shares worth $1.44M. The position accounts for 0.03% of the portfolio, ranked #495.

Chicago Partners Investment Group first reported a position in REGN in Q4 2014 and has held it in 8 quarters since. The position peaked at $1.49M in Q1 2026. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Chicago Partners Investment Group held 2,209 shares of Regeneron Pharmaceuticals worth $1.44M as of Q2 2026.
Chicago Partners Investment Group bought 208 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $142K.
Regeneron Pharmaceuticals made up 0.03% of Chicago Partners Investment Group's portfolio in Q2 2026, its #495 holding.
Chicago Partners Investment Group first reported a position in Regeneron Pharmaceuticals in Q4 2014 and has held it in 8 quarters since.
Chicago Partners Investment Group's Regeneron Pharmaceuticals position peaked at $1.49M in Q1 2026.
1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Chicago Partners Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.